These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 672637)

  • 21. [Use of spectroscopic methods in drug analysis].
    Spiteller G
    Arzneimittelforschung; 1975 Jul; 25(7a):1140-8. PubMed ID: 1242343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of gas chromatography and mass spectrometry in forensic chemistry for the demonstration of drugs and their metabolites].
    Chundela B; Slechtová R
    Beitr Gerichtl Med; 1974; 32():206-14. PubMed ID: 4468785
    [No Abstract]   [Full Text] [Related]  

  • 23. A microcomputer-directed mass spectrometer as a compound-selective detector for gas chromatography.
    Strauss PA; Hertel RH
    J Chromatogr; 1977 Apr; 134(1):39-48. PubMed ID: 870504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry of medicines. Quantitative determination by direct probe inlet system mass chromatography.
    Tatematsu A; Yoshizumi H; Nadai T; Kubodera T; Asai S
    Biomed Mass Spectrom; 1978 Mar; 5(3):192-7. PubMed ID: 24482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of dangerous drugs by mass spectrometry.
    Law NC; Aandahl V; Fales HM; Milne GW
    Clin Chim Acta; 1971 Apr; 32(2):221-8. PubMed ID: 4399316
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification and quantification of drugs in human amniotic fluid.
    Sommer KR; Hill RM; Horning MG
    Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):583-95. PubMed ID: 1197933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mass spectrometry assay: technics and development].
    Mignot A; Fourtillan JB
    Therapie; 1987 Sep; 42(5):423-7. PubMed ID: 3441884
    [No Abstract]   [Full Text] [Related]  

  • 28. An integrated methodological approach to the computer-assisted gas chromatographic screening of basic drugs in biological fluids using nitrogen selective detection.
    Dugal R; Massé R; Sanchez G; Bertrand MJ
    J Anal Toxicol; 1980; 4(1):1-12. PubMed ID: 6927043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of biological samples for gas chromatographic analysis].
    Zavattini G
    Boll Chim Farm; 1976 Feb; 115(2):65-79. PubMed ID: 949363
    [No Abstract]   [Full Text] [Related]  

  • 30. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An introduction to drug testing: the expanding role of mass spectrometry.
    Hammett-Stabler C; Cotten SW
    Methods Mol Biol; 2012; 902():1-13. PubMed ID: 22767103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gas chromatographic--mass spectrometric analysis of optically active metabolites and drugs on a novel chiral stationary phase.
    Frank H; Nicholson GJ; Bayer E
    J Chromatogr; 1978 Sep; 146(2):197-206. PubMed ID: 701418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rational evaluation of results of chromatographic analysis].
    Tomásková V; Tomásek V
    Cesk Farm; 1977 Sep; 26(7):287-9. PubMed ID: 603916
    [No Abstract]   [Full Text] [Related]  

  • 35. The application of gas chromatography/atmospheric pressure chemical ionisation time-of-flight mass spectrometry to impurity identification in Pharmaceutical Development.
    Bristow T; Harrison M; Sims M
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1673-81. PubMed ID: 20486265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites.
    Hammar CG; Holmstedt B; Lindgren JE; Tham R
    Adv Pharmacol Chemother; 1969; 7():53-89. PubMed ID: 4910171
    [No Abstract]   [Full Text] [Related]  

  • 37. Achievements and future trends in the analysis of emerging organic contaminants in environmental samples by mass spectrometry and bioanalytical techniques.
    Farré M; Kantiani L; Petrovic M; Pérez S; Barceló D
    J Chromatogr A; 2012 Oct; 1259():86-99. PubMed ID: 22877973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The general toxicology unknown. I. The systematic approach.
    Wu Chen NB; Schaffer MI; Lin RL; Kurland ML; Donoghue ER; Stein RJ
    J Forensic Sci; 1983 Apr; 28(2):391-7. PubMed ID: 6345717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modern methods for analysis of psychoactive drugs and metabolites.
    Holmstedt B
    Nord Psykiatr Tidsskr; 1971; 25(1):56-8. PubMed ID: 5112749
    [No Abstract]   [Full Text] [Related]  

  • 40. Mass spectrometry and clinical chemistry.
    Hill RE; Whelan DT
    Clin Chim Acta; 1984 Jun; 139(3):231-94. PubMed ID: 6378430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.